NOX 4.17% 6.9¢ noxopharm limited

Ann: Veyonda Survival Advantage in LuPSMA Therapy Confirmed, page-23

  1. 7,515 Posts.
    lightbulb Created with Sketch. 337
    OK mice models are 100% indicative of outcomes in humans confused.png - I don't get excited about mice models after 2015 when I was all aboard until I researched - some old hands on here taught me some valuable lessons - expensive but valuable about PS announcements on masse!

    Talking about PS - I see still no news on the noxcovid results - might call back in 3 months cool.png
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.